Report ID: SQMIG35J2113
Antifungal Agents Market Size, Share, Growth Analysis, By Drug Type(Echinocandins, Azoles, Ployenes, Allylamines), By Therapeutic Indication(Aspergillosis, Dermatophytosis, Candidiasis, and Others), By Application(Powders, Ointments, Drugs, and Pastes), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35J2113 |
Region:
Global |
Published Date: May, 2024
Pages:
219
|
Tables:
94 |
Figures:
76
Antifungal Agents Market Dynamics
Drivers
High Prevalence of Fungal Infections
- Widespread antibiotic resistance and growing incidence of infectious chronic diseases are key factors responsible for increasing fungal infections among patients, which in turn, is projected to boost antifungal agent demand outlook.
Advancements in Antifungal Drug Development
- High investments in medical and pharmaceutical R&D have led to significant advancements in antifungal drug development. These advancements are estimated to favor sales of antifungal agents in the future.
Restraints
Antifungal Resistance
- Fungal pathogens are developing resistance to widely used antifungal agents and this has resulted in an epidemic of antifungal resistance that is rendering antifungal agents useless in most cases. This antifungal resistance could hurt market growth in the future.
Limited Spectrum
- Antifungal agent for one infection might not work for another and this is why most antifungal agents have a limited spectrum of fungal infections that they can tackle. This limited spectrum of action is what will impede antifungal agents market development across the forecast period and beyond.
Antifungal Agents Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
